BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27552093)

  • 1. Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.
    Zakowski MF; Rekhtman N; Auger M; Booth CN; Crothers B; Ghofrani M; Khalbuss W; Laucirica R; Moriarty AT; Tabatabai ZL; Barkan GA
    Arch Pathol Lab Med; 2016 Oct; 140(10):1116-20. PubMed ID: 27552093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
    Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
    Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
    Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
    Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.
    Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A
    Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
    Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
    Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
    Sun PL; Jin Y; Kim H; Lee CT; Jheon S; Chung JH
    Cancer Cytopathol; 2013 Jun; 121(6):311-9. PubMed ID: 23225576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?
    Vigliar E; Malapelle U; Bellevicine C; de Luca C; Troncone G
    Cytopathology; 2015 Oct; 26(5):312-7. PubMed ID: 25376259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.
    Minca EC; Lanigan CP; Reynolds JP; Wang Z; Ma PC; Cicenia J; Almeida FA; Pennell NA; Tubbs RR
    J Thorac Oncol; 2014 Apr; 9(4):464-8. PubMed ID: 24736067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
    Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
    Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
    Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid on-site evaluation has high diagnostic yield differentiating adenocarcinoma vs squamous cell carcinoma of non-small cell lung carcinoma, not otherwise specified subgroup.
    Celik B; Khoor A; Bulut T; Nassar A
    Pathol Oncol Res; 2015 Jan; 21(1):167-72. PubMed ID: 24889857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma.
    Yamagishi T; Shimizu K; Ochi N; Yamane H; Irei I; Sadahira Y; Takigawa N; Oka M; Nakata M
    Diagn Pathol; 2014 May; 9():103. PubMed ID: 24885169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative fine needle aspirations - diagnosis and typing of lung cancer in small biopsies: challenges and limitations.
    Biancosino C; Krüger M; Vollmer E; Welker L
    Diagn Pathol; 2016 Jul; 11(1):59. PubMed ID: 27388913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.